002198 嘉应制药
已收盘 12-12 15:00:00
资讯
新帖
简况
嘉应制药完成公司章程修订及工商备案登记
中金财经 · 12-02
嘉应制药完成公司章程修订及工商备案登记
嘉应制药：部分产品涉及感冒咽喉肿痛类
证券之星 · 11-28
嘉应制药：部分产品涉及感冒咽喉肿痛类
广东嘉应制药被出具警示函，涉未按规定披露日常关联交易情况等
蓝鲸财经 · 11-22
广东嘉应制药被出具警示函，涉未按规定披露日常关联交易情况等
异动快报：嘉应制药（002198）11月18日9点53分触及跌停板
证券之星 · 11-18
异动快报：嘉应制药（002198）11月18日9点53分触及跌停板
11月17日嘉应制药（002198）龙虎榜数据：游资上塘路上榜
证券之星 · 11-17
11月17日嘉应制药（002198）龙虎榜数据：游资上塘路上榜
股市必读：嘉应制药11月14日涨停收盘，收盘价7.66元
证券之星 · 11-17
股市必读：嘉应制药11月14日涨停收盘，收盘价7.66元
异动快报：嘉应制药（002198）11月14日10点14分触及涨停板
证券之星 · 11-14
异动快报：嘉应制药（002198）11月14日10点14分触及涨停板
嘉应制药(002198)9月30日股东户数2.45万户，较上期减少0.91%
证券之星 · 10-29
嘉应制药(002198)9月30日股东户数2.45万户，较上期减少0.91%
图解嘉应制药三季报：第三季度单季净利润同比增长161.26%
证券之星 · 10-28
图解嘉应制药三季报：第三季度单季净利润同比增长161.26%
嘉应制药（002198）披露拟续聘会计师事务所公告，10月27日股价下跌0.92%
证券之星 · 10-27
嘉应制药（002198）披露拟续聘会计师事务所公告，10月27日股价下跌0.92%
嘉应制药（002198）披露全资子公司变更经营范围暨完成工商变更登记，10月23日股价上涨0.62%
证券之星 · 10-23
嘉应制药（002198）披露全资子公司变更经营范围暨完成工商变更登记，10月23日股价上涨0.62%
嘉应制药（002198）披露修订公司章程及调整员工持股计划，10月16日股价下跌0.91%
证券之星 · 10-16
嘉应制药（002198）披露修订公司章程及调整员工持股计划，10月16日股价下跌0.91%
嘉应制药(002198)9月30日股东户数2.45万户，较上期减少0.91%
证券之星 · 10-14
嘉应制药(002198)9月30日股东户数2.45万户，较上期减少0.91%
股市必读：嘉应制药(002198)股东户数2.47万户，较上期增加1.11%
证券之星 · 09-16
股市必读：嘉应制药(002198)股东户数2.47万户，较上期增加1.11%
嘉应制药：累计回购公司股份10396000股
证券日报网 · 09-02
嘉应制药：累计回购公司股份10396000股
嘉应制药中报解读：净利润增逾2.5倍，“提质增效+创新双驱”战略成效卓著
证券之星 · 08-28
嘉应制药中报解读：净利润增逾2.5倍，“提质增效+创新双驱”战略成效卓著
嘉应制药（002198）2025年中报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 08-27
嘉应制药（002198）2025年中报简析：营收净利润同比双双增长，应收账款上升
嘉应制药股价微涨0.45% 上半年净利润同比增254.33%
金融界 · 08-25
嘉应制药股价微涨0.45% 上半年净利润同比增254.33%
嘉应制药：上半年净利润2008.26万元，同比增长254.33%
格隆汇 · 08-25
嘉应制药：上半年净利润2008.26万元，同比增长254.33%
嘉应制药(002198)7月31日股东户数2.44万户，较上期减少4.43%
证券之星 · 08-07
嘉应制药(002198)7月31日股东户数2.44万户，较上期减少4.43%
加载更多
公司概况
公司名称：
广东嘉应制药股份有限公司
所属行业：
医药制造业
上市日期：
2007-12-18
主营业务：
广东嘉应制药股份有限公司的主营业务是中成药的研发、生产和销售。公司的主要产品是双料喉风散、双料喉风含片、重感灵片、银翘解毒颗粒、橘红痰咳颗粒、接骨七厘片、接骨七厘胶囊、消炎利胆片、金菊五花茶颗粒、壮腰健肾丸、固精参茸丸。
发行价格：
5.99
{"stockData":{"symbol":"002198","market":"SZ","secType":"STK","nameCN":"嘉应制药","latestPrice":6.92,"timestamp":1765523031000,"preClose":7.01,"halted":0,"volume":13599600,"delay":0,"changeRate":-0.0128,"floatShares":507000000,"shares":508000000,"eps":0.0779,"marketStatus":"已收盘","change":-0.09,"latestTime":"12-12 15:00:00","open":6.97,"high":7.01,"low":6.75,"amount":93831200,"amplitude":0.0371,"askPrice":6.93,"askSize":38,"bidPrice":6.92,"bidSize":110,"shortable":0,"etf":0,"ttmEps":0.0779,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":7.01,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":7.71,"lowLimit":6.31,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":507509848,"isCdr":false,"pbRate":5.02,"roa":"--","peRate":88.831836,"roe":"2.97%","epsLYR":0.0406,"committee":0.064599,"marketValue":3512000000,"turnoverRate":0.0268,"status":1,"floatMarketCap":3512000000},"requestUrl":"/m/hq/s/002198","defaultTab":"news","newsList":[{"id":"2588037267","title":"嘉应制药完成公司章程修订及工商备案登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2588037267","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588037267?lang=zh_cn&edition=full","pubTime":"2025-12-02 19:39","pubTimestamp":1764675563,"startTime":"0","endTime":"0","summary":"中访网数据 广东嘉应制药股份有限公司于近日完成《公司章程》修订及相关工商备案登记手续。此前，公司于2025年10月31日召开的2025年第二次临时股东大会审议通过了关于修订《公司章程》的议案。本次修订完成后，公司已取得梅州市市场监督管理局下发的备案登记许可。经确认，本次备案的《公司章程》内容与公司此前披露的版本无差异。此次工商变更的完成，标志着公司治理结构的相关调整已正式落地。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251202/31839238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002198","BK0239","BK0077"],"gpt_icon":0},{"id":"2586567270","title":"嘉应制药：部分产品涉及感冒咽喉肿痛类","url":"https://stock-news.laohu8.com/highlight/detail?id=2586567270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586567270?lang=zh_cn&edition=full","pubTime":"2025-11-28 11:48","pubTimestamp":1764301686,"startTime":"0","endTime":"0","summary":"证券之星消息，嘉应制药(002198)11月27日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘！公司新建生产线现在满负荷生产吗？最近甲流严重！嘉应制药回复：尊敬的投资者，公司部分产品涉及感冒、咽喉肿痛类，目前生产依据计划和市场情况有序进行，谢谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800013092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","002198"],"gpt_icon":0},{"id":"2585855175","title":"广东嘉应制药被出具警示函，涉未按规定披露日常关联交易情况等","url":"https://stock-news.laohu8.com/highlight/detail?id=2585855175","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585855175?lang=zh_cn&edition=full","pubTime":"2025-11-22 13:35","pubTimestamp":1763789710,"startTime":"0","endTime":"0","summary":"蓝鲸新闻11月22日讯，近日，广东证监局发布了行政监管措施决定书，剑指广东嘉应制药股份有限公司及公司相关责任人李能、游永平、史俊平、肖巧霞。决定书显示，广东嘉应制药股份有限公司存在以下问题：未按规定披露对外财务资助情况；未按规定披露公司日常关联交易情况。嘉应制药时任董事长李能、总经理游永平、财务总监史俊平和董事会秘书肖巧霞未按照《上市公司信息披露管理办法》的相关规定履行勤勉尽责义务，对公司上述违规事项负有主要责任。根据相关规定，广东证监局决定对嘉应制药及李能、游永平、史俊平、肖巧霞采取出具警示函的行政监管措施。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1763728113954081790","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0239","BK0077","002198"],"gpt_icon":0},{"id":"2584601508","title":"异动快报：嘉应制药（002198）11月18日9点53分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2584601508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584601508?lang=zh_cn&edition=full","pubTime":"2025-11-18 09:55","pubTimestamp":1763430929,"startTime":"0","endTime":"0","summary":"证券之星11月18日盘中消息，9点53分嘉应制药（002198）触及跌停板。目前价格7.64，下跌9.37%。其所属行业中药目前下跌。领涨股为ST葫芦娃。该股为医药，养老产业，中药概念热股。11月17日的资金流向数据方面，主力资金净流入6281.8万元，占总成交额19.12%，游资资金净流出3936.61万元，占总成交额11.98%，散户资金净流出2345.18万元，占总成交额7.14%。近5日资金流向一览见下表：嘉应制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800008779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","002198"],"gpt_icon":0},{"id":"2584564612","title":"11月17日嘉应制药（002198）龙虎榜数据：游资上塘路上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2584564612","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584564612?lang=zh_cn&edition=full","pubTime":"2025-11-17 17:32","pubTimestamp":1763371922,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年11月17日公布的交易公开信息显示，嘉应制药因连续三个交易日内，涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年11月17日收盘，嘉应制药报收于8.43元，上涨10.05%，已连续涨停2天，换手率7.69%，成交量39.02万手，成交额3.29亿元。从龙虎榜公布的三日买卖数据来看，机构合计净卖出5043.62万元。上塘路等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700023443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002198","BK0077"],"gpt_icon":0},{"id":"2584660072","title":"股市必读：嘉应制药11月14日涨停收盘，收盘价7.66元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584660072","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584660072?lang=zh_cn&edition=full","pubTime":"2025-11-17 01:30","pubTimestamp":1763314230,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，嘉应制药报收于7.66元，上涨10.06%，涨停，换手率5.43%，成交量27.55万手，成交额2.03亿元。当日关注点来自交易信息汇总：嘉应制药11月14日涨停收盘，封单资金达3.61亿元，占其流通市值9.29%。交易信息汇总股价提醒嘉应制药11月14日涨停收盘，收盘价7.66元。资金流向11月14日主力资金净流入2495.62万元；游资资金净流出1439.98万元；散户资金净流出1055.63万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700000558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002198","BK0239"],"gpt_icon":0},{"id":"2583427445","title":"异动快报：嘉应制药（002198）11月14日10点14分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2583427445","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583427445?lang=zh_cn&edition=full","pubTime":"2025-11-14 10:15","pubTimestamp":1763086521,"startTime":"0","endTime":"0","summary":"证券之星11月14日盘中消息，10点14分嘉应制药触及涨停板。目前价格7.15，上涨2.73%。其所属行业中药目前上涨。领涨股为众生药业。该股为中药，医药，养老产业概念热股，当日中药概念上涨1.83%，医药概念上涨1.32%，养老产业概念上涨1.01%。11月13日的资金流向数据方面，主力资金净流出521.62万元，占总成交额6.72%，游资资金净流入145.49万元，占总成交额1.87%，散户资金净流入376.13万元，占总成交额4.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400010027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198","BK0077","BK0239"],"gpt_icon":0},{"id":"2579697881","title":"嘉应制药(002198)9月30日股东户数2.45万户，较上期减少0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579697881","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579697881?lang=zh_cn&edition=full","pubTime":"2025-10-29 17:27","pubTimestamp":1761730070,"startTime":"0","endTime":"0","summary":"证券之星消息，近日嘉应制药披露，截至2025年9月30日公司股东户数为2.45万户，较9月10日减少226.0户，减幅为0.91%。在中药行业个股中，嘉应制药股东户数低于行业平均水平，截至9月30日，中药行业平均股东户数为5.34万户。从股价来看，2025年9月10日至2025年9月30日，嘉应制药区间跌幅为4.62%，在此期间股东户数减少226.0户，减幅为0.91%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900036013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198","BK0077","BK0239"],"gpt_icon":0},{"id":"2578380956","title":"图解嘉应制药三季报：第三季度单季净利润同比增长161.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578380956","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578380956?lang=zh_cn&edition=full","pubTime":"2025-10-28 19:47","pubTimestamp":1761652079,"startTime":"0","endTime":"0","summary":"证券之星消息，嘉应制药2025年三季报显示，公司主营收入2.93亿元，同比上升13.03%；归母净利润2179.43万元，同比上升658.5%；扣非净利润2014.25万元，同比上升1171.96%；其中2025年第三季度，公司单季度主营收入9449.86万元，同比上升19.01%；单季度归母净利润171.17万元，同比上升161.26%；单季度扣非净利润135.39万元，同比上升144.51%；负债率8.48%，投资收益-11.72万元，财务费用-33.3万元，毛利率56.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800036295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198"],"gpt_icon":0},{"id":"2578612427","title":"嘉应制药（002198）披露拟续聘会计师事务所公告，10月27日股价下跌0.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578612427","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578612427?lang=zh_cn&edition=full","pubTime":"2025-10-27 18:32","pubTimestamp":1761561177,"startTime":"0","endTime":"0","summary":"截至2025年10月27日收盘，嘉应制药报收于6.47元，较前一交易日下跌0.92%，最新总市值为32.84亿元。该股当日开盘6.52元，最高6.57元，最低6.41元，成交额达4910.14万元，换手率为1.49%。公司近日发布公告，披露将于2025年10月31日召开2025年第二次临时股东大会，会议将审议多项议案。其中，备受投资者关注的一项议案为拟续聘众华会计师事务所为公司2025年度审计机构，相关审计费用将由管理层根据定价原则协商确定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700028583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002198","BK0077"],"gpt_icon":0},{"id":"2577858530","title":"嘉应制药（002198）披露全资子公司变更经营范围暨完成工商变更登记，10月23日股价上涨0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577858530","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577858530?lang=zh_cn&edition=full","pubTime":"2025-10-23 22:40","pubTimestamp":1761230423,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，嘉应制药报收于6.49元，较前一交易日上涨0.62%，最新总市值为32.94亿元。近日，嘉应制药发布公告称，其全资子公司嘉应制药（湖南）有限公司因业务发展需要，对其经营范围进行变更，并已完成工商变更登记手续，取得新的《营业执照》。变更后，许可项目包括：药品生产、委托生产、进出口、批发、零售；食品生产与销售；保健食品生产；医用口罩生产；化妆品生产等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300038066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002198","BK0077"],"gpt_icon":0},{"id":"2575871991","title":"嘉应制药（002198）披露修订公司章程及调整员工持股计划，10月16日股价下跌0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575871991","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575871991?lang=zh_cn&edition=full","pubTime":"2025-10-16 17:16","pubTimestamp":1760606193,"startTime":"0","endTime":"0","summary":"截至2025年10月16日收盘，嘉应制药报收于6.51元，较前一交易日下跌0.91%，最新总市值为33.04亿元。公司近日发布公告称，于2025年10月15日召开第七届董事会第九次临时会议，审议通过《关于修订<公司章程>并办理工商变更登记的议案》，尚需提交股东大会审议。会议同时调整2024年员工持股计划参与人数至不超过65人，并新增孙俊、曾勇为参与对象，关联董事已回避表决。本次董事会还决定召开2025年第二次临时股东大会，审议相关议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101600026652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","002198"],"gpt_icon":0},{"id":"2575298881","title":"嘉应制药(002198)9月30日股东户数2.45万户，较上期减少0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575298881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575298881?lang=zh_cn&edition=full","pubTime":"2025-10-14 17:16","pubTimestamp":1760433419,"startTime":"0","endTime":"0","summary":"证券之星消息，近日嘉应制药披露，截至2025年9月30日公司股东户数为2.45万户，较9月10日减少226.0户，减幅为0.91%。在中药行业个股中，嘉应制药股东户数低于行业平均水平，截至9月30日，中药行业平均股东户数为5.28万户。从股价来看，2025年9月10日至2025年9月30日，嘉应制药区间跌幅为4.62%，在此期间股东户数减少226.0户，减幅为0.91%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400053691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002198","BK0239"],"gpt_icon":0},{"id":"2567448061","title":"股市必读：嘉应制药(002198)股东户数2.47万户，较上期增加1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567448061","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567448061?lang=zh_cn&edition=full","pubTime":"2025-09-16 02:57","pubTimestamp":1757962630,"startTime":"0","endTime":"0","summary":"截至2025年9月15日收盘，嘉应制药报收于6.44元，下跌0.16%，换手率0.97%，成交量4.91万手，成交额3147.6万元。来自股本股东变化：截至2025年9月10日，嘉应制药股东户数较7月31日增加1.11%，户均持股数量下降至2.05万股，表明筹码略有分散。股本股东变化股东户数变动近日嘉应制药披露，截至2025年9月10日公司股东户数为2.47万户，较7月31日增加272.0户，增幅为1.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091600001870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002198","BK0239"],"gpt_icon":0},{"id":"2564385976","title":"嘉应制药：累计回购公司股份10396000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2564385976","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564385976?lang=zh_cn&edition=full","pubTime":"2025-09-02 21:46","pubTimestamp":1756820760,"startTime":"0","endTime":"0","summary":"证券日报网讯9月2日晚间，嘉应制药（维权）发布公告称，截至2025年8月31日，公司通过集中竞价交易方式已累计回购公司股份10，396，000股，达到公司当前总股本的比例为2.048%。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-02/doc-infpciyx6670356.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-02/doc-infpciyx6670356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002198","BK0239","BK0077"],"gpt_icon":0},{"id":"2562085574","title":"嘉应制药中报解读：净利润增逾2.5倍，“提质增效+创新双驱”战略成效卓著","url":"https://stock-news.laohu8.com/highlight/detail?id=2562085574","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562085574?lang=zh_cn&edition=full","pubTime":"2025-08-28 15:45","pubTimestamp":1756367144,"startTime":"0","endTime":"0","summary":"8月25日，嘉应制药发布2025年半年度报告，报告期实现营业收入1.99亿元，同比增长10.40%；归属上市公司股东的净利润2008.26万元，同比增长254.33%。2025年上半年，嘉应制药研发投入481.37万元，同比增长15.95%，延续了持续增长的态势。嘉应制药参股小犀牛健康科技(陕西)有限公司，持股比例2.13%。总结嘉应制药2025年半年报不仅是一次业绩的爆发，更是公司战略转型的阶段性答卷。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025082800025914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198"],"gpt_icon":0},{"id":"2562639347","title":"嘉应制药（002198）2025年中报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2562639347","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562639347?lang=zh_cn&edition=full","pubTime":"2025-08-27 06:19","pubTimestamp":1756246771,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期嘉应制药发布2025年中报。截至本报告期末，公司营业总收入1.99亿元，同比上升10.4%，归母净利润2008.26万元，同比上升254.33%。按单季度数据看，第二季度营业总收入7730.47万元，同比下降9.89%，第二季度归母净利润467.93万元，同比上升863.71%。本报告期嘉应制药应收账款上升，应收账款同比增幅达38.36%。本次财报公布的各项数据指标表现尚佳。去年的净利率为5.48%，算上全部成本后，公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700008437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198"],"gpt_icon":0},{"id":"2562281262","title":"嘉应制药股价微涨0.45% 上半年净利润同比增254.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562281262","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562281262?lang=zh_cn&edition=full","pubTime":"2025-08-25 22:40","pubTimestamp":1756132824,"startTime":"0","endTime":"0","summary":"嘉应制药最新股价为6.76元，较前一交易日上涨0.45%。盘中最高触及6.79元，最低下探至6.66元，成交量为12.26万手，成交金额达0.82亿元。该公司属于医药制造业中的中药细分领域，主要从事中成药研发、生产和销售。根据最新披露的2025年半年报显示，嘉应制药上半年实现营业收入1.99亿元，同比增长10.4%；归母净利润2008.26万元，同比增长254.33%；基本每股收益0.0396元。从资金流向来看，8月25日主力资金净流出69.21万元，近五个交易日累计净流出1246.22万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/25224052678611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002198"],"gpt_icon":0},{"id":"2562124760","title":"嘉应制药：上半年净利润2008.26万元，同比增长254.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562124760","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562124760?lang=zh_cn&edition=full","pubTime":"2025-08-25 21:40","pubTimestamp":1756129245,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0077","BK0239","002198"],"gpt_icon":0},{"id":"2557079558","title":"嘉应制药(002198)7月31日股东户数2.44万户，较上期减少4.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557079558","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557079558?lang=zh_cn&edition=full","pubTime":"2025-08-07 17:16","pubTimestamp":1754558163,"startTime":"0","endTime":"0","summary":"证券之星消息，近日嘉应制药披露，截至2025年7月31日公司股东户数为2.44万户，较6月20日减少1133.0户，减幅为4.43%。在中药行业个股中，嘉应制药股东户数低于行业平均水平，截至7月31日，中药行业平均股东户数为5.39万户。从股价来看，2025年6月20日至2025年7月31日，嘉应制药区间涨幅为12.9%，在此期间股东户数减少1133.0户，减幅为4.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080700028113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002198","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765753454173,"stockEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0029},{"period":"3month","weight":0.0729},{"period":"6month","weight":0.1143},{"period":"1year","weight":-0.2478},{"period":"ytd","weight":-0.0546}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东嘉应制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"27015人(较上一季度增加10.34%)","perCapita":"18785股","listingDate":"2007-12-18","address":"广东省梅州市梅江区东升工业园B区","registeredCapital":"50750万元","survey":" 广东嘉应制药股份有限公司的主营业务是中成药的研发、生产和销售。公司的主要产品是双料喉风散、双料喉风含片、重感灵片、银翘解毒颗粒、橘红痰咳颗粒、接骨七厘片、接骨七厘胶囊、消炎利胆片、金菊五花茶颗粒、壮腰健肾丸、固精参茸丸。","listedPrice":5.99},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"嘉应制药(002198)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供嘉应制药(002198)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"嘉应制药,002198,嘉应制药股票,嘉应制药股票老虎,嘉应制药股票老虎国际,嘉应制药行情,嘉应制药股票行情,嘉应制药股价,嘉应制药股市,嘉应制药股票价格,嘉应制药股票交易,嘉应制药股票购买,嘉应制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"嘉应制药(002198)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供嘉应制药(002198)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}